Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: A scoping review NUTRIENTS 2020
Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19 CIRCULATION RESEARCH 2020
Is teicoplanin a complementary treatment option for COVID-19? The question remains INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2020
Long-Term safety and efficacy of adalimumab in psoriasis. A multicentric study focused on infections (connecting study) POSTEPY DERMATOLOGII I ALERGOLOGII 2020
Effects of non-invasive ventilation on renal and endothelial function in patients with respiratory failure EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2020
Heart, COVID-19, and echocardiography ECHOCARDIOGRAPHY 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection EMERGING MICROBES & INFECTIONS 2020
Impact of ifn-free and ifn-based treatment on blood myeloid dendritic cell, monocyte, slan-dc, and activated t lymphocyte dynamics during hcv infection JOURNAL OF IMMUNOLOGY RESEARCH 2020
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial JOURNAL OF TRANSLATIONAL MEDICINE 2020
Management of psoriatic patients in biologic treatment associated with infectious comorbidities POSTEPY DERMATOLOGII I ALERGOLOGII 2020
Physical activity and HIV. Effects on fitness status, metabolism, inflammation and immune-activation AIDS AND BEHAVIOR 2020
Epidemiology of Chronic Pain in the Latium Region, Italy. a Cross-sectional Study on the Clinical Characteristics of Patients Attending Pain Clinics PAIN MANAGEMENT NURSING 2019
Italian Consensus Recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis MODERN RHEUMATOLOGY 2019
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2019
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 HIV MEDICINE 2019
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients SCIENTIFIC REPORTS 2019
Epidemiology and microbiology of skin and soft tissue infections: preliminary results of a National registry JOURNAL OF CHEMOTHERAPY 2019
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis OPEN FORUM INFECTIOUS DISEASES 2019
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2019
HepaDisk – A new quality of life questionnaire for HCV patients DIGESTIVE AND LIVER DISEASE 2019

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma